I agree that this site is using cookies. You can find further informations here.
X
Holko, Przemysław
42  results:
OpenAccess-fulltext X
Search for persons X
?
1

Comparative safety of tyrosine kinase inhibitors in the tre..:

Krawczyk, Kinga ; Śladowska, Katarzyna ; Holko, Przemysław.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512702/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Out-of-pocket expenses of patients with inflammatory bowel ..:

Holko, Przemysław ; Kawalec, Paweł ; Sajak-Szczerba, Magdalena..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406674/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Effectiveness of fixed-dose combination therapy in hyperten..:

Kawalec, Paweł ; Holko, Przemysław ; Gawin, Małgorzata.
Archives of Medical Science, T. 14, nr 5, s. 1125-1136.  , 2018
Link: https://ruj.uj.edu.pl/xm..
 
?
4

Effectiveness of fixed-dose combination therapy in hyperten..:

Kawalec, Paweł ; Holko, Przemysław ; Gawin, Małgorzata.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111352/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
5

Impact of biologic treatment of Cohn's disease on the rate ..:

Holko, Przemysław ; Kawalec, Paweł ; Pilc, Andrzej
Frontiers in Pharmacology, T. 9.  , 2018
Link: https://ruj.uj.edu.pl/xm..
 
?
6

Cost-effectiveness analysis of Crohn's disease treatment wi..:

Holko, Przemysław ; Kawalec, Paweł ; Pilc, Andrzej
PharmacoEconomics, T. 36, nr 7, s. 853-865.  , 2018
Link: https://ruj.uj.edu.pl/xm..
 
?
7

Comment on: "Forecasting Pharmaceutical Prices for Economic..:

Holko, Przemysław
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691809/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
8

Health-related quality of life impairment and indirect cost..:

Holko, Przemysław ; Kawalec, Paweł ; Mossakowska, Małgorzata.
PLoS ONE, T. 11, nr 12.  , 2016
Link: https://ruj.uj.edu.pl/xm..
 
?
9

Economic evaluation of single-pill combination of indapamid..:

Kawalec, Paweł ; Holko, Przemysław ; Stawowczyk, Ewa..
Kardiologia Polska = Polish Heart Journal, T. 73, nr 9, s. 761-767.  , 2015
Link: https://ruj.uj.edu.pl/xm..
 
?
10

Administration of conestat alfa, human C1 esterase inhibito..:

Kawalec, Paweł ; Holko, Przemysław ; Paszulewicz, Anna.
Pneumonologia i Alergologia Polska, T. 81, nr 2, s. 95-104.  , 2013
Link: https://ruj.uj.edu.pl/xm..
 
?
11

Cost-utility analysis of Ruconest® (conestat alfa) compared..:

Kawalec, Paweł ; Holko, Przemysław ; Paszulewicz, Anna
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834719.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
12

A Comment on Craig et al.: ''Retigabine for the Adjunctive ..:

Holko, Przemysław ; Kawalec, Paweł
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671124.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
13

Anakinra w leczeniu reumatoidalnego zapalenia stawów u doro..:

Kawalec, Paweł ; Holko, Przemysław ; Paszulewicz, Anna
Reumatologia, T. 51, nr 2, s. 119-126.  , 2013
Link: https://ruj.uj.edu.pl/xm..
 
?
14

Sipuleucel-T immunotherapy for castration-resistant prostat..:

Kawalec, Paweł ; Paszulewicz, Anna ; Holko, Przemysław.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506233.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
15

Sipuleucel-T immunotherapy for castration-resistant prostat..:

Kawalec, Paweł ; Paszulewicz, Anna ; Holko, Przemysław.
Archives of Medical Science, T. 8, nr 5, s. 767-775.  , 2012
Link: https://ruj.uj.edu.pl/xm..
 
1-15